10.89USD+1.21%Mkt Cap: 672.72M $P/E: 68.061d ago
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management u…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$321.33MUSD
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
Indicators:|
Key Statistics
Company
Market Cap672.72M $
Enterprise Value690.98M $
Revenue (TTM)495.59M $
Gross Profit326.47M $
Net Income (TTM)2.31M $
Revenue/Share8.226 USD
Last Price10.89 USD
Fiscal Year EndJan 2026
MR QuarterApr 2026
Employees1.8K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISINUS71944F1066
Valuation
P/E (Trailing)68.06
P/E (Forward)6.78
PEG—
EV/EBITDA21.05
EV/Revenue1.39
P/S1.36
P/B1.87
EPS (TTM)0.16
EPS (Forward)1.61
52W Range
7.77012% of range32.76
52W High32.76 USD
52W Low7.770 USD
Profitability
Gross Margin67.93%
Oper. Margin5.15%
EBITDA Margin6.62%
Profit Margin0.48%
ROE0.68%
ROA0.35%
Growth
Revenue Growth12.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF78.81M $
CapEx (TTM)24.40M $
FCF Margin11.37%
FCF Yield8.38%
Net Debt17.85M $
Net Debt/EBITDA0.54
Balance Sheet
Debt/Equity0.30
Current Ratio1.76
Quick Ratio1.43
Book Value/Sh5.813 USD
Cash/Share1.209 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)13.94 USD
Upside (mean)+28.0%
Target Range9.000 USD – 20.00 USD
$9.000+28.0% to mean$20.00
# Analysts17
Ownership
Shares Out.61.77M
Float49.94M
Insiders4.38%
Institutions97.91%
Short Interest
Short Ratio2.6d
Short % Float6.92%
Short % Out.5.61%
Shares Short3.47M
Short (prev mo.)3.35M
Technical
SMA 509.743 (+11.8%)
SMA 20014.35 (-24.1%)
Beta0.87
S&P 52W Chg19.63%
Avg Vol (30d)792.76K
Avg Vol (10d)767.54K
Technical Indicators
RSI (14)60.8
MACD0.3749
MACD Signal0.3490
MACD Hist.+0.0259
BB Upper11.75 USD
BB Middle10.28 USD
BB Lower8.795 USD
BB Width28.80%
ATR (14)0.4779 USD
Vol Ratio (20d)0.56x